Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1994 May;31(5):360–363. doi: 10.1136/jmg.31.5.360

Aspartylglucosaminuria in northern Norway: a molecular and genealogical study.

O K Tollersrud 1, O Nilssen 1, L Tranebjaerg 1, O Borud 1
PMCID: PMC1049865  PMID: 8064811

Abstract

Aspartylglucosaminuria (AGU, McKusick 208400) is an autosomal recessive lysosomal storage disorder. Ninety percent of all patients are from Finland and only sporadic cases have been reported from elsewhere. In northern Norway, however, nine patients from seven families have been diagnosed with AGU. All these Norwegian patients were homozygous for the most prevalent Finnish AGU mutation (AGUFin) and show the polymorphism uniquely associated with AGUFin in Finland. Genealogical investigation of nine parents proved Finnish ancestry in all pedigrees. Therefore, AGU in Norway most likely resulted from immigration of Finnish carriers. These Finnish immigrants originated mostly from the Tornio valley area in northern Finland in a continuous immigration movement from 1700 to 1900. The majority settled in the western part of northern Norway, leading to a "cluster" of AGU in that particular area. The Finnish immigrants intermixed considerably with Lapps and these two ethnic origins should thus be considered as high risk groups for AGUFin in northern Norway.

Full text

PDF
360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson N. N., Jr, Kuranda M. J. Lysosomal degradation of Asn-linked glycoproteins. FASEB J. 1989 Dec;3(14):2615–2622. doi: 10.1096/fasebj.3.14.2531691. [DOI] [PubMed] [Google Scholar]
  2. Autio S. Aspartylglycosaminuria. Analysis of thirty-four patients. J Ment Defic Res. 1972;1(0):1–93. [PubMed] [Google Scholar]
  3. Borud O., Torp K. H. Letter: Aspartylglycosaminuria in Northern Norway. Lancet. 1976 May 15;1(7968):1082–1083. doi: 10.1016/s0140-6736(76)92266-2. [DOI] [PubMed] [Google Scholar]
  4. Fisher K. J., Aronson N. N., Jr Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163----Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunits. J Biol Chem. 1991 Jun 25;266(18):12105–12113. [PubMed] [Google Scholar]
  5. Fisher K. J., Tollersrud O. K., Aronson N. N., Jr Cloning and sequence analysis of a cDNA for human glycosylasparaginase. A single gene encodes the subunits of this lysosomal amidase. FEBS Lett. 1990 Sep 3;269(2):440–444. doi: 10.1016/0014-5793(90)81211-6. [DOI] [PubMed] [Google Scholar]
  6. Ikonen E., Baumann M., Grön K., Syvänen A. C., Enomaa N., Halila R., Aula P., Peltonen L. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J. 1991 Jan;10(1):51–58. doi: 10.1002/j.1460-2075.1991.tb07920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ikonen E., Enomaa N., Ulmanen I., Peltonen L. In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutation. Genomics. 1991 Sep;11(1):206–211. doi: 10.1016/0888-7543(91)90120-4. [DOI] [PubMed] [Google Scholar]
  8. Makino M., Kojima T., Ohgushi T., Yamashina I. Studies on enzymes acting on glycopeptides. J Biochem. 1968 Feb;63(2):186–192. doi: 10.1093/oxfordjournals.jbchem.a128760. [DOI] [PubMed] [Google Scholar]
  9. Nilssen O., Tollersrud O. K., Borud O., Tranebjaerg L. A simple and rapid PCR based method for AGU(Fin) determination. Hum Mol Genet. 1993 Apr;2(4):484–484. doi: 10.1093/hmg/2.4.484. [DOI] [PubMed] [Google Scholar]
  10. Nylander P. O., Beckman L. Population studies in northern Sweden. XVII. Estimates of Finnish and Saamish influence. Hum Hered. 1991;41(3):157–167. doi: 10.1159/000153995. [DOI] [PubMed] [Google Scholar]
  11. Park H., Fisher K. J., Aronson N. N., Jr Genomic structure of human lysosomal glycosylasparaginase. FEBS Lett. 1991 Aug 19;288(1-2):168–172. doi: 10.1016/0014-5793(91)81027-6. [DOI] [PubMed] [Google Scholar]
  12. Pollitt R. J., Jenner F. A., Merskey H. Aspartylglycosaminuria. An inborn error of metabolism associated with mental defect. Lancet. 1968 Aug 3;2(7562):253–255. doi: 10.1016/s0140-6736(68)92355-6. [DOI] [PubMed] [Google Scholar]
  13. Syvänen A. C., Ikonen E., Manninen T., Bengtström M., Söderlund H., Aula P., Peltonen L. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. Genomics. 1992 Mar;12(3):590–595. doi: 10.1016/0888-7543(92)90452-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES